Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
ToppCellfacs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DDN PLD4

2.11e-04144728bd042f12186f36bc5aabf6a0232270a448f4b58
ToppCellInt-URO-Other|Int-URO / Disease, Lineage and Cell Type

PLD4 SEMA5A

2.32e-0415172ea5f25842e621be41a6491c9959d419d9cc7ebd6
ToppCellInt-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type

PLD4 SEMA5A

2.32e-04151720344d482f1c55c9eaa15beb8d6bac1c6cdca21b3
ToppCelldroplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN PLD4

2.39e-04153722731c3d4ac40ecc22108f8f3f45a069077159125
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

2.39e-0415372c1335e7d7407412431ed4d8c7dfcb2c6086d8483
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SEMA5A HECTD2

2.58e-04159727cda111bb98f1241989e49d490bdf51a712ea589
ToppCellsevere_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2)

ABHD18 GARRE1

2.61e-0416072a1181ef36b453eba53b04d836aa9f65a71354cdb
ToppCellURO-Other|URO / Disease, Lineage and Cell Type

PLD4 SEMA5A

2.61e-0416072b0923e6bacfaba8ca40aa5706bf270eea0938b0a
ToppCellURO-Other-RBC|URO / Disease, Lineage and Cell Type

PLD4 SEMA5A

2.61e-0416072558f3b0719e2461a69e1b93b08e21675e8d07a5a
ToppCellsevere_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2)

ABHD18 GARRE1

2.64e-041617282196139cdbbd70a36957a87bc9ac6d02575da3f
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN HECTD2

2.77e-04165721b7dfa173e83aa8c46a3153a3261866c065c3b73
ToppCellfacs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN HECTD2

2.77e-0416572b4f7d33af7d053ec07b01bd67d861600a9c4822e
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

2.88e-0416872fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

2.88e-0416872e96859dbf51cf8c4def8ee8db132f4d874fb4381
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

2.88e-0416872315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCelldroplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN HECTD2

2.91e-041697287116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DDN PLD4

2.94e-0417072b49f7c8a27078de2137ed04f74cfee30729cfa5e
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

2.94e-041707260bbd738c12e64e483485586c30057304884f5a6
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

2.98e-0417172f047a0cc2ce0a062ec502aa9cb91b1202f437f29
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.01e-04172726c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.01e-0417272381ae1c3c07d0a424f43455ec571653b192a946a
ToppCelldroplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLD4 SEMA5A

3.05e-04173729ba55e21d1037ec3150d77895e52f0b051df65da
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SEMA5A HECTD2

3.08e-0417472f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.08e-0417472dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCellCOVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

DDN SEMA5A

3.12e-0417572a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DDN GARRE1

3.12e-0417572f5451c29c487b998778e50349b3d774d5e20fd28
ToppCellILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TEX13D PLD4

3.15e-0417672b9f847dd55703e413f3cd815eef5724fffaf13b3
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.19e-04177724d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCellControl-Myeloid-pDC|Control / Disease state, Lineage and Cell class

PLD4 SEMA5A

3.19e-04177723940663bb5b45b2ca9f772550380a516c53e410b
ToppCellControl-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class

PLD4 SEMA5A

3.19e-0417772e82115bfc32c7b689460fbc5caeb983c1aabe30f
ToppCellControl-Myeloid-pDC|World / Disease state, Lineage and Cell class

PLD4 SEMA5A

3.23e-041787220ef63d925e67ddd5955832312ca8574a6f838a4
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.23e-0417872edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HECTD2 GARRE1

3.26e-04179726bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.26e-04179727394e77e665bf16d3733df91bb12907be460ab44
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.26e-0417972c1c0b7186a0eab8c76404b95f1cf8d64b1b45cb1
ToppCellfacs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN PLD4

3.30e-041807282965ed1b72a1873c24dd4553d39681596057316
ToppCellfacs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN PLD4

3.30e-0418072bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.30e-0418072d685fa2b013bc085dbef7c40956ed3043f83e483
ToppCellfacs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN PLD4

3.30e-0418072839defb40f7cfb2711e9025194de636533f51bcd
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDN PLD4

3.30e-041807264f01494a4052186773720e10b4e7c724ff94547
ToppCell3'_v3-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue

PLD4 SEMA5A

3.34e-041817266d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue

PLD4 SEMA5A

3.34e-04181723d7f089fb434fbc989f1fa159e22133ae00b2487
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.34e-04181725bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.34e-04181728e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA5A HECTD2

3.37e-0418272678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.37e-0418272cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SEMA5A HECTD2

3.37e-04182728d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCellCOVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type

DDN SEMA5A

3.41e-0418372fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.41e-04183727c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.41e-0418372612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.41e-0418372848fc6dd129150897ee339343e83c645b6e779eb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.41e-0418372eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.48e-04185729197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCellnormal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

PLD4 SEMA5A

3.48e-04185723091870a5bf8ecb963e560b47c8502bae367416c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.48e-0418572b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.48e-0418572ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCellhealthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass

PLD4 SEMA5A

3.52e-0418672916f2aeea4989ba7a29e071e348a51010f010223
ToppCellAnterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SEMA5A HECTD2

3.52e-041867232af3f211f9ad5d5c6b86b83325cfbf2f8466b56
ToppCellcontrol-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PLD4 SEMA5A

3.52e-0418672fe31e9cf4575ee40b50489593c51d8c36c3cc532
ToppCellhealthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass

PLD4 SEMA5A

3.52e-041867245f66619e45d590c7365a51782d4ac46b7d31fde
ToppCellcontrol-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

PLD4 SEMA5A

3.52e-0418672fccee4cfcc887358cf916d974f29627095b5ad9c
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.52e-04186721094c7140131454b2583200e1c01e81ccab3db23
ToppCellnormal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass

PLD4 SEMA5A

3.56e-0418772a3592f056e1c2f82ba325fea2ecc4dd6c6347c81
ToppCellnormal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass

PLD4 SEMA5A

3.56e-0418772d36751372fd40a46441f07735c9c3c5dcb503f24
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.56e-041877224c2a3962da364e46e98abeab5f8234376fa26bb
ToppCellPBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

PLD4 SEMA5A

3.60e-0418872879054b780378ae05be68e597c77c931bf0ade03
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.60e-04188729db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCellEndothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

TEX13D GARRE1

3.60e-04188720824d567356d360fd8e78e840c30529c139f98a1
ToppCellPBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

PLD4 SEMA5A

3.60e-0418872de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCellPBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

PLD4 SEMA5A

3.60e-041887289411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCellCOVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class

PLD4 SEMA5A

3.60e-0418872a75c2cf2f8dae343c13aaa66b637658b935ed10a
ToppCellCOVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class

PLD4 SEMA5A

3.60e-041887262d33d2990d4a2d32bd0863147e47f656df1966e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.60e-0418872047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCellCOVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class

PLD4 SEMA5A

3.64e-0418972c6cfd6aa21c19f2c62d80218bbc924e14e82aada
ToppCellPBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PLD4 SEMA5A

3.64e-0418972209cae68d78c8f72479b169e27c3ff7e143adece
ToppCellPBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PLD4 SEMA5A

3.64e-041897298ca646231fbd5f29827c2dd31ac4503026bad7d
ToppCell3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue

PLD4 SEMA5A

3.64e-04189726c2ace61a7d62bcf7e76b73e2da8b722d03e713b
ToppCellPBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PLD4 SEMA5A

3.64e-0418972a9ad1fb12304541f909dd0eeac9b9eb28c31fd41
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.67e-041907292710caaff05123cf8e909319d7ac441d9b31a66
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue

PLD4 SEMA5A

3.67e-0419072dde0e34f6a06cdbbb65c86472360c09f0279a572
ToppCellControl-Other-RBC|Control / Disease, Lineage and Cell Type

PLD4 SEMA5A

3.67e-041907235b254564d01c839c63f9af159a46d368852cf15
ToppCellNS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SEMA5A HECTD2

3.67e-04190727be0f2ff86ca8500a43e0d44e5e292530f9ba0bb
ToppCellControl-Other|Control / Disease, Lineage and Cell Type

PLD4 SEMA5A

3.67e-04190723be5497909b48bf05c623586880f225bb101b430
ToppCell3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue

PLD4 SEMA5A

3.67e-04190726892c603037b61ef88d6ca01b7592dc0d347d63b
ToppCellCOVID-19_Moderate-pDC|World / disease group, cell group and cell class

PLD4 SEMA5A

3.71e-041917293adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.75e-0419272ef0aba777072429a6ab7dcfcc305673975946580
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.79e-04193723eaa0461618582a1754400624350d269d24e750a
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DDN SEMA5A

3.83e-041947243eb677a76634bb9a48a40e0d607c4936ae64bcc
ToppCellmild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PLD4 SEMA5A

3.95e-04197720cb00daa6943f7a7fb34a8fdf51188646af65686
ToppCellmild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PLD4 SEMA5A

3.95e-041977215230a54fa5903dd728de1a0ad633bd2d2c7a04d
ToppCellSepsis-URO-Others|URO / Disease, condition lineage and cell class

PLD4 SEMA5A

3.99e-04198726caab5266da666cfbe92ac1ace26ad2004e5aa09
ToppCellSepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class

PLD4 SEMA5A

3.99e-0419872d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50
ToppCellSepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class

PLD4 SEMA5A

3.99e-041987229203aaa5c1844f72289e03f585cd5e7fc498a9a
ToppCellSepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class

PLD4 SEMA5A

3.99e-041987267f721ea8e60042317ba12efd584f56b07cfb29d
ToppCellControl-Control-Others-RBC|Control / Disease, condition lineage and cell class

PLD4 SEMA5A

4.03e-0419972eb4c52d04f572433c0239bf479d0040a309939a1
ToppCellCOVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class

PLD4 SEMA5A

4.03e-04199729de61e5189d907cc969ac3043d68204f70acc0bf
ToppCellSepsis-Int-URO-Myeloid-pDC|Int-URO / Disease, condition lineage and cell class

PLD4 SEMA5A

4.03e-0419972a41c3c3360b1b4546c9b2c49bda595feef6a4a4a
DrugNisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A

DDN ABHD18 SEMA5A

1.20e-05194635091_UP
DrugDichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A

DDN ABHD18 SEMA5A

1.25e-05197636686_DN
Drug1,2-dipalmitoy

DDN PLD4

6.22e-054762CID000003098
DrugPhenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A

DDN GARRE1

8.44e-04173626451_UP
Drugtroglitazone; Up 200; 10uM; PC3; HT_HG-U133A

DDN SEMA5A

8.44e-04173621232_UP
Drug0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A

DDN SEMA5A

9.03e-04179623630_UP
DrugChlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; PC3; HT_HG-U133A

DDN SEMA5A

9.03e-04179625074_UP
DrugLY 294002; Up 200; 10uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

9.74e-04186624460_UP
Drugpioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A

DDN SEMA5A

9.74e-04186625930_UP
DrugCP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A

DDN SEMA5A

1.01e-03189627537_UP
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.02e-03190624493_DN
DrugMuramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.02e-03190624582_DN
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.03e-03191624283_DN
Drug0393-0188; Up 200; 10uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.04e-03192627536_UP
DrugBendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.05e-03193624315_DN
DrugPhenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A

DDN ABHD18

1.05e-03193626699_DN
DrugCGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A

DDN ABHD18

1.06e-03194626417_DN
DrugPrilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.06e-03194624284_DN
DrugCyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.06e-03194624470_DN
DrugICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A

DDN ABHD18

1.06e-03194626165_DN
DrugHydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.06e-03194626660_DN
DrugRapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A

DDN ABHD18

1.07e-03195624466_DN
DrugLeflunomide [75706-12-6]; Up 200; 14.8uM; PC3; HT_HG-U133A

DDN SEMA5A

1.07e-03195625884_UP
DrugMevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A

ABHD18 GARRE1

1.07e-03195623459_DN
DrugMafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A

ABHD18 GARRE1

1.08e-03196625079_DN
DrugST021200; Down 200; 10uM; PC3; HT_HG-U133A

DDN GARRE1

1.08e-03196627559_DN
DrugPepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A

DDN SEMA5A

1.08e-03196624206_DN
DrugTridihexethyl chloride; Up 200; 11.4uM; HL60; HT_HG-U133A

DDN SEMA5A

1.08e-03196622964_UP
DrugSB 202190; Up 200; 1uM; PC3; HT_HG-U133A

DDN ABHD18

1.08e-03196626882_UP
Drugbeta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; PC3; HT_HG-U133A

DDN ABHD18

1.08e-03196626638_DN
DrugOxyphenbutazone [129-20-4]; Down 200; 12.4uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197624506_DN
DrugDoxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197624610_UP
DrugRauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197625800_DN
DrugSTOCK1N-28457; Up 200; 20uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197626864_UP
Drug1,5-Isoquinolinediol; Up 200; 100uM; HL60; HG-U133A

ABHD18 GARRE1

1.09e-0319762543_UP
DrugTerconazole [67915-31-5]; Down 200; 7.6uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197624583_DN
DrugHecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

ABHD18 SEMA5A

1.09e-03197623457_UP
DrugFluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197625741_UP
DrugSulfinpyrazone [57-96-5]; Up 200; 9.8uM; PC3; HT_HG-U133A

DDN SEMA5A

1.09e-03197625753_UP
DrugBenzonatate [104-31-4]; Up 200; 6.6uM; HL60; HT_HG-U133A

DDN GARRE1

1.09e-03197621843_UP
DrugNU1025; Down 200; 100uM; MCF7; HG-U133A

ABHD18 SEMA5A

1.09e-0319762608_DN
DrugRapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A

DDN ABHD18

1.09e-03197626167_DN
DrugOndansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.09e-03197625796_DN
DrugGliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A

ABHD18 GARRE1

1.09e-03197622870_DN
DrugIproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A

DDN SEMA5A

1.10e-03198622288_UP
DrugAmitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A

DDN SEMA5A

1.10e-03198626353_DN
DrugReserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A

DDN SEMA5A

1.10e-03198626603_DN
DrugOleandomycin phosphate [7060-74-4]; Up 200; 5uM; PC3; HT_HG-U133A

DDN SEMA5A

1.10e-03198624615_UP
DrugAcetazolamide [59-66-5]; Up 200; 18uM; HL60; HT_HG-U133A

DDN GARRE1

1.10e-03198621850_UP
DrugMyosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.10e-03198624293_DN
DrugTiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A

DDN ABHD18

1.11e-03199627362_UP
DrugAdiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A

DDN ABHD18

1.11e-03199627279_DN
DrugTamoxifen citrate [54965-24-1]; Up 200; 7uM; PC3; HT_HG-U133A

DDN SEMA5A

1.11e-03199622050_UP
DrugErgocryptine-alpha [511-09-1]; Down 200; 7uM; PC3; HT_HG-U133A

DDN SEMA5A

1.11e-03199624552_DN
DrugPirlindole mesylate [60762-57-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A

DDN SEMA5A

1.11e-03199626519_UP
DrugIodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.11e-03199625085_UP
DrugCarbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A

DDN ABHD18

1.11e-03199625093_UP
DrugCatechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; PC3; HT_HG-U133A

DDN SEMA5A

1.11e-03199624255_DN
DrugAld1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A

DDN SEMA5A

1.11e-03199627547_DN
Drugclofibrate; Up 200; 100uM; MCF7; HG-U133A

ABHD18 SEMA5A

1.11e-0319962444_UP
DrugChenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ABHD18 GARRE1

1.11e-03199627433_DN
DrugPF-00875133-00 [351322-64-0]; Up 200; 10uM; PC3; HT_HG-U133A

DDN SEMA5A

1.11e-03199625928_UP
DrugCefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.11e-03199625787_DN
DrugOxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A

DDN SEMA5A

1.11e-03199625094_UP
DrugRacecadotril [81110-73-8]; Up 200; 10.4uM; PC3; HT_HG-U133A

ABHD18 SEMA5A

1.13e-03200625755_UP
DrugAC1L1GEZ

DDN PLD4

1.13e-0320062CID000003653
DrugPralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A

DDN SEMA5A

1.13e-03200626283_UP
Diseasesusceptibility to vaginal yeast infection measurement

ABHD18 HECTD2

9.96e-056572EFO_0008412
Diseaseneuroticism measurement, cognitive function measurement

DDN HECTD2

7.24e-0356672EFO_0007660, EFO_0008354

Protein segments in the cluster

PeptideGeneStartEntry
NWPKPMPLIPCLSWS

ABHD18

211

Q0P651
WFPKCWIPSPKKQPP

DDN

381

O94850
EEFPPITKCSWWIPS

HECTD2

301

Q5U5R9
WKAAVAPTWPCSMPP

PLD4

6

Q96BZ4
KTKTWPPKAPWQHPS

GARRE1

971

O15063
CPELKKTTPWTPWTP

SEMA5A

701

Q13591
KPASFPVPVNWKCPW

TEX13D

671

A0A0J9YY54